NCT00032058View on ClinicalTrials.gov

Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Diagnosing the Extent of Disease in Patients With Prostate Cancer

NACompletedINTERVENTIONAL
Timeline

Start Date

June 30, 2003

Primary Completion Date

June 30, 2006

Conditions
Prostate Cancer
Interventions
PROCEDURE

magnetic resonance imaging

PROCEDURE

magnetic resonance spectroscopic imaging

Trial Locations (8)

10021

Memorial Sloan-Kettering Cancer Center, New York

55905

Mayo Clinic Cancer Center, Rochester

94143-0628

UCSF Comprehensive Cancer Center, San Francisco

06520

Yale Comprehensive Cancer Center, New Haven

21231-2410

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

02115

Brigham and Women's Hospital, Boston

19104-4283

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

77030-4009

M.D. Anderson Cancer Center at University of Texas, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

American College of Radiology Imaging Network

NETWORK

NCT00032058 - Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Diagnosing the Extent of Disease in Patients With Prostate Cancer | Biotech Hunter | Biotech Hunter